Sorry, you need to enable JavaScript to visit this website.

Trudell Medical Limited closes on purchase of Vyaire Medical RDx, to rebrand RDx as Jaeger Medical 

London, Canada, November 13, 2024 – Trudell Medical Limited has closed on the purchase of the RDx business unit of Vyaire Medical. 

The closing of the sale ensures the continuation of service to RDx customers as Trudell Medical will operate RDx as a separate business unit and maintain operations in Germany and California.

RDx manufactures respiratory diagnostic products that are used in hospitals and private clinics worldwide and are trusted by specialists in the respiratory community to help enable, enhance and extend lives. 

The acquisition will increase Trudell Medical’s already strong market position in aerosol drug delivery and lung health devices by adding premium respiratory diagnostics to its industry-leading aerosol drug delivery and lung health devices. 

The Vyntus™ ONE Pulmonary Function System and Body Plethysmography System, Vyntus™ CPX Metabolic Cart, will be added to Trudell Medical’s product portfolio that includes the AEROCHAMBER*, AEROBIKA* OPEP, AEROECLIPSE Nebulizer devices.
 

Jaeger Medical: A new era, a familiar name

The RDx business unit will be rebranded as Jaeger Medical, a return to the company’s roots in being named after its Founder, Erich Jaeger, who produced the first respiratory stress testing device—in 1954. This innovation set the stage for the continuous refinement of respiratory diagnostics over the past 70 years. 

Customers, suppliers and partners of Vyaire RDx can expect to receive information from RDx contacts regarding this change.

Quotes

“Trudell Medical and Jaeger are two names synonymous with respiratory health acrss the healthcare industry. The closing of the sale is a historic day for both organizations as we move forward to enter a new era of excellence in respiratory healthcare innovation. We are excited to combine our products, people and passion for helping people breathe easier through our industry-leading products and services."
-George Baran, Executive Chair, Trudell Medical Limited

“We are very familiar with RDx diagnostic products as Trudell Healthcare Solutions has been a successful distribution partner for RDx in Canada. This relationship serves as a foundation, along with our shared values and a focus on patient-focused solutions. This acquisition is energizing our teams and creating new opportunities to propel innovation and the long-term growth of our company.”
-Gerald Slemko, CEO, Trudell Medical Limited

“The sale allows the RDx Business Unit to move forward with a mandate to continue to serve our customers and patients with industry-leading respiratory diagnostics. Trudell Medical has been an outstanding partner for Vyaire RDx in Canada and has clearly aligned values, making it a great fit for our team and products. Jaeger and Trudell Medical will work together closely to ensure a smooth transition for our team members, customers, and partners.”
-Will Throp, CEO, RDx

 

About Trudell Medical Limited

Our focus is on respiratory care, select areas of the hospital operating room and providing pathways for virtual care. Our vision is to provide patients throughout the world with medical devices and services that make their lives better. 

Over the years the Trudell Medical Group has grown to a family of six operating companies that are overseen and supported by Trudell Medical Limited, our corporate entity. Trudell Medical Limited has been named one of Canada’s Best Managed Companies three years in a row.

Visit TrudellMedicalGroup.com for more information.

 

About Jaeger Medical

Jaeger Medical has a rich history of thinking forward and bringing cutting-edge solutions to the caregivers and patients we serve. Our vision is to be the foremost global leader in respiratory diagnostics, providing customers in over 100 countries with innovative and integrated solutions that improve patient lives.

 

For more information, please contact: 

Adam Nyp
Digital Communications Specialist
1-226-577-9623
adam.nyp@tmlcorp.com